Evidence for specific mechanisms are now emerging, for example the description of raised granulocyte-colony stimulating factor (G-CSF) in tumor development and consequent bone marrow reprogramming, with activation of a myeloid differentiation program in the early hematopoietic compartment, and an expansion of T cell-suppressive myeloid cells [8]. The gene discussed is CSF3; the disease is neoplasm.